TY - JOUR
T1 - Effects of a single-dose of pre-emptive pregabalin on postoperative pain and opioid consumption after double-jaw surgery
T2 - A randomized controlled trial
AU - Ahiskalioglu, Ali
AU - Ince, Ilker
AU - Aksoy, Mehmet
AU - Yalcin, Ertan
AU - Ahiskalioglu, Elif Oral
AU - Kilinc, Adnan
N1 - Publisher Copyright:
© 2016 American Association of Oral and Maxillofacial Surgeons.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Purpose The effect of a single-dose of pre-emptive pregabalin is still unknown, although it is used as an adjuvant in controlling acute postoperative pain. The purpose of this study was to evaluate the effects of pre-emptive single-dose pregabalin on postoperative acute pain and 24-hour opioid consumption in patients who underwent double-jaw surgery. Patients and Methods Forty patients (18 to 45 yr old; American Society of Anesthesiologists status I to II) for whom elective double-jaw surgery was planned under general anesthesia were included in this study, which had been planned as a prospective, randomized, and double-blinded study. Patients were randomly divided into 2 groups: the pregabalin group (n = 20) was given pregabalin 150 mg orally 1 hour before general anesthesia and the placebo group (n = 20) was given an oral placebo capsule. The groups were administered the routine general anesthesia protocol. Postoperative analgesia was performed intravenously in the 2 groups twice a day with dexketoprofen trometamol 50 mg and patient-controlled analgesia with fentanyl. Postoperative analgesia was evaluated using the visual analog scale (VAS). Fentanyl consumption, additional analgesia requirement, and side-effects were recorded during the first 24 hours after surgery. Descriptive and bivariate statistics were computed, and significance was set at a P value less than.05. Results Compared with placebo, the VAS score was statistically lower in the pregabalin group during the early postoperative period (P <.05). The 24-hour opioid consumption was significantly higher in the placebo group compared with the pregabalin group (509.40 ± 261.56 vs 260.10 ± 246.53 μq, respectively; P =.004). In addition, the analgesia requirement was statistically lower in the pregabalin group (P <.05). Nausea or vomiting was observed more often in the placebo group, whereas other side-effects were similar for the 2 groups. Conclusion A single 150-mg dose of pre-emptive pregabalin decreased postoperative opioid consumption in the first 24 hours after double-jaw surgery. Multimodal analgesia techniques that contain pre-emptive analgesia can be used successfully in preventing postoperative pain caused by orthognathic surgery.
AB - Purpose The effect of a single-dose of pre-emptive pregabalin is still unknown, although it is used as an adjuvant in controlling acute postoperative pain. The purpose of this study was to evaluate the effects of pre-emptive single-dose pregabalin on postoperative acute pain and 24-hour opioid consumption in patients who underwent double-jaw surgery. Patients and Methods Forty patients (18 to 45 yr old; American Society of Anesthesiologists status I to II) for whom elective double-jaw surgery was planned under general anesthesia were included in this study, which had been planned as a prospective, randomized, and double-blinded study. Patients were randomly divided into 2 groups: the pregabalin group (n = 20) was given pregabalin 150 mg orally 1 hour before general anesthesia and the placebo group (n = 20) was given an oral placebo capsule. The groups were administered the routine general anesthesia protocol. Postoperative analgesia was performed intravenously in the 2 groups twice a day with dexketoprofen trometamol 50 mg and patient-controlled analgesia with fentanyl. Postoperative analgesia was evaluated using the visual analog scale (VAS). Fentanyl consumption, additional analgesia requirement, and side-effects were recorded during the first 24 hours after surgery. Descriptive and bivariate statistics were computed, and significance was set at a P value less than.05. Results Compared with placebo, the VAS score was statistically lower in the pregabalin group during the early postoperative period (P <.05). The 24-hour opioid consumption was significantly higher in the placebo group compared with the pregabalin group (509.40 ± 261.56 vs 260.10 ± 246.53 μq, respectively; P =.004). In addition, the analgesia requirement was statistically lower in the pregabalin group (P <.05). Nausea or vomiting was observed more often in the placebo group, whereas other side-effects were similar for the 2 groups. Conclusion A single 150-mg dose of pre-emptive pregabalin decreased postoperative opioid consumption in the first 24 hours after double-jaw surgery. Multimodal analgesia techniques that contain pre-emptive analgesia can be used successfully in preventing postoperative pain caused by orthognathic surgery.
UR - http://www.scopus.com/inward/record.url?scp=84955635756&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84955635756&partnerID=8YFLogxK
U2 - 10.1016/j.joms.2015.09.008
DO - 10.1016/j.joms.2015.09.008
M3 - Article
C2 - 26433040
AN - SCOPUS:84955635756
SN - 0278-2391
VL - 74
SP - 53.e1-53.e7
JO - Journal of Oral and Maxillofacial Surgery
JF - Journal of Oral and Maxillofacial Surgery
IS - 1
ER -